Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Castel

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Medicina Clinica|October 10, 1992
[The physician and self medication]J R Laporte, J M Castel
Revista De Neurologia|June 25, 2002
[The evolution of use of anti-Parkinson drugs in Spain]E Montané, A Vallano Ferraz, J M Castel
Medicina Clinica|May 11, 1991
[Pharmacokinetics of acetylsalicylic acid for the prophylaxis of cardiovascular pathology]J M Castel, M A Artaza, J R Laporte
British Journal of Clinical Pharmacology|July 1, 1990
Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effectJ M Castel, E Cappiello, D Leopaldi, et al.
The Annals of Pharmacotherapy|July 1, 1993
Gemfibrozil-induced impotenceA Figueras, J M Castel, J R LaPorte, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulationsA Figueras, D Capellà, J M Castel, et al.
The Science of the Total Environment|December 15, 2015
Characterization and typification of small ruminant farms providing fuelbreak grazing services for wildfire prevention in Andalusia (Spain)Y Mena, J Ruiz-Mirazo, F A Ruiz, et al.
Medicina Clinica|February 20, 1988
[Which of the various acetylsalicylic acid preparations is the most appropriate in each indication? A pharmacokinetic study]M A Artaza, J M Castel, E Cusidó, et al.
BMJ (Clinical Research Ed.)|September 17, 1988
Parkinsonism, tremor, and depression induced by cinnarizine and flunarizineD Capellà, J R Laporte, J M Castel, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Identification of propafenone metaboliser phenotype from plasma and urine excretion dataR Latini, M Belloni, R Bernasconi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Medicina Clinica|October 10, 1992
[The physician and self medication]J R Laporte, J M Castel
Revista De Neurologia|June 25, 2002
[The evolution of use of anti-Parkinson drugs in Spain]E Montané, A Vallano Ferraz, J M Castel
Medicina Clinica|May 11, 1991
[Pharmacokinetics of acetylsalicylic acid for the prophylaxis of cardiovascular pathology]J M Castel, M A Artaza, J R Laporte
British Journal of Clinical Pharmacology|July 1, 1990
Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effectJ M Castel, E Cappiello, D Leopaldi, et al.
The Annals of Pharmacotherapy|July 1, 1993
Gemfibrozil-induced impotenceA Figueras, J M Castel, J R LaPorte, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulationsA Figueras, D Capellà, J M Castel, et al.
The Science of the Total Environment|December 15, 2015
Characterization and typification of small ruminant farms providing fuelbreak grazing services for wildfire prevention in Andalusia (Spain)Y Mena, J Ruiz-Mirazo, F A Ruiz, et al.
Medicina Clinica|February 20, 1988
[Which of the various acetylsalicylic acid preparations is the most appropriate in each indication? A pharmacokinetic study]M A Artaza, J M Castel, E Cusidó, et al.
BMJ (Clinical Research Ed.)|September 17, 1988
Parkinsonism, tremor, and depression induced by cinnarizine and flunarizineD Capellà, J R Laporte, J M Castel, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Identification of propafenone metaboliser phenotype from plasma and urine excretion dataR Latini, M Belloni, R Bernasconi, et al.
Pageof 2